Global University Venturing

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Stanford Daper Fund-backed Boatsetter has increased its series A to at least $27.8m with $10m from investors including WestCap Group and Valor Equity Partners.

Gene therapy developer Renovacor, a Temple University spinout, has secured series A funding from investors including Novartis Venture Fund.

Doxly has become the first exit for the IU Philanthropic Venture Fund after its acquisition by Litera Microsystems.

SnapGene, a molecular biology documentation spinout of UChicago, has been acquired by scientific data analysis tool provider GraphPad Software.

Indiana University's IURTC has become IU Ventures with a purview dedicated to administering the Philanthropic Venture Fund, angel network and entrepreneurial support services.

Osage University Partners is among the series B investors backing Virginia Tech-linked IBD therapy disease developer Landos Biopharma, which is preparing phase 2 trials.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The spinout has revealed it added approximately $6m to a series A round backed by University of Pennsylvania and IP Group last year, bringing its total size to about $59m.

Royal Vopak, Mitsubishi and Covestro helped the Erlangen–Nuremberg hydrogen storage technology spinout collect $19m in funding.

Last year there was a peak in number of IPOs of corporate-backed emerging business, while the first half of 2019 hosted some much-awaited flotations like those of Uber, Lyft and Slack. We look at the broader picture for corporate-backed companies going public.